Ondine Biomedical Inc. (LON:OBI – Get Free Report) traded down 3.6% during mid-day trading on Friday . The company traded as low as C$13.00 and last traded at C$13.50. 1,041,652 shares were traded during trading, an increase of 136% from the average session volume of 442,030 shares. The stock had previously closed at C$14.00.
Ondine Biomedical Price Performance
The business’s fifty day moving average is C$12.89 and its 200-day moving average is C$10.84. The company has a debt-to-equity ratio of 76.45, a current ratio of 0.97 and a quick ratio of 8.26. The firm has a market cap of C$7.01 billion, a PE ratio of -1.93 and a beta of 0.27.
About Ondine Biomedical
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.
Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.
Read More
- Five stocks we like better than Ondine Biomedical
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
- 3 ETFs For the Coming Genomics Revolution
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
